Reply to: "Reply to: 'Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries'".
dc.contributor.author | da Silva Filipe, A | en_US |
dc.contributor.author | Sreenu, V | en_US |
dc.contributor.author | Hughes, J | en_US |
dc.contributor.author | Aranday-Cortes, E | en_US |
dc.contributor.author | Irving, WL | en_US |
dc.contributor.author | Foster, GR | en_US |
dc.contributor.author | Agarwal, K | en_US |
dc.contributor.author | Rosenberg, W | en_US |
dc.contributor.author | Macdonald, D | en_US |
dc.contributor.author | Richardson, P | en_US |
dc.contributor.author | Aldersley, MA | en_US |
dc.contributor.author | Wiselka, M | en_US |
dc.contributor.author | Ustianowski, A | en_US |
dc.contributor.author | McLauchlan, J | en_US |
dc.contributor.author | Thomson, EC | en_US |
dc.date.accessioned | 2018-05-11T08:16:46Z | |
dc.date.available | 2017-11-22 | en_US |
dc.date.issued | 2018-01-12 | en_US |
dc.date.submitted | 2018-03-29T14:36:09.797Z | |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/37583 | |
dc.language | eng | en_US |
dc.relation.ispartof | J Hepatol | en_US |
dc.title | Reply to: "Reply to: 'Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries'". | en_US |
dc.type | Article | |
dc.rights.holder | © 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. | |
dc.identifier.doi | 10.1016/j.jhep.2017.11.044 | en_US |
pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/29339112 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published online | en_US |
dcterms.dateAccepted | 2017-11-22 | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Centre for Immunobiology [1121]